Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 235, Issue 5, Pages 4217-4226Publisher
WILEY
DOI: 10.1002/jcp.29376
Keywords
cell therapy; premature ovarian failure; regenerative medicine; scaffold; stem cell; tissue engineering
Categories
Funding
- Tabriz University of Medical Sciences [98-149]
Ask authors/readers for more resources
Premature ovarian failure (POF) usually happens former to the age of 40 and affects the female physiological state premenopausal period. In this condition, ovaries stop working long before the expected menopausal time. Of diagnostic symptoms of the disease, one can mention amenorrhea and hypoestrogenism. The cause of POF in most cases is idiopathic; however, cancer therapy may also cause POF. Commonly utilized therapies such as hormone therapy, in-vitro activation, and regenerative medicine are the most well-known treatments for POF. Hence, these therapies may be associated with some complications. The aim of the present study is to discuss the beneficial effects of tissue engineering for fertility rehabilitation in patients with POF as a newly emerging therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available